Cargando…

Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review

Programmed cell death protein 1 (PD-1) inhibition plays a central role in the current treatment of recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC). Some patients achieve a durable response, and even complete remission (CR) is possible, though it occurs rarely. In cases of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stöth, Manuel, Meyer, Till, Gehrke, Thomas, Hagen, Rudolf, Scheich, Matthias, Hackenberg, Stephan, Scherzad, Agmal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561138/ https://www.ncbi.nlm.nih.gov/pubmed/37818135 http://dx.doi.org/10.3892/ol.2023.14076

Ejemplares similares

Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
por: Meyer, Till Jasper, et al.
Publicado: (2021)

Head and neck squamous cancer cells enhance the differentiation of human mesenchymal stem cells to adipogenic and osteogenic linages in vitro
por: Meyer, Till Jasper, et al.
Publicado: (2022)

Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study
por: Scherzad, Agmal, et al.
Publicado: (2023)

Surgical management of lateral neck abscesses in children: a retrospective analysis of 100 cases
por: Tecle, Nyat-Eyob, et al.
Publicado: (2022)

Deep neck infections with and without mediastinal involvement: treatment and outcome in 218 patients
por: Gehrke, Thomas, et al.
Publicado: (2021)

Surgical management of tympanojugular paragangliomas using the flexible CO(2) laser
por: Hackenberg, Stephan, et al.
Publicado: (2022)

Current Understanding of Nasal Epithelial Cell Mis-Differentiation
por: Scherzad, Agmal, et al.
Publicado: (2019)

Ag- but Not ZnO-Nanoparticles Disturb the Airway Epithelial Barrier at Subtoxic Concentrations
por: Moratin, Helena, et al.
Publicado: (2023)

Molecular Mechanisms of Zinc Oxide Nanoparticle-Induced Genotoxicity Short Running Title: Genotoxicity of ZnO NPs
por: Scherzad, Agmal, et al.
Publicado: (2017)

Erratum: Scherzad, A., et al. Molecular Mechanisms of Zinc Oxide Nanoparticle-Induced Genotoxicity Short Running Title: Genotoxicity of ZnO NPs. Materials 2017, 10, 1427
por: Scherzad, Agmal, et al.
Publicado: (2020)

Investigation of the Immune Modulatory Potential of Zinc Oxide Nanoparticles in Human Lymphocytes
por: Moratin, Helena, et al.
Publicado: (2021)

Time-Dependent Toxic and Genotoxic Effects of Zinc Oxide Nanoparticles after Long-Term and Repetitive Exposure to Human Mesenchymal Stem Cells
por: Ickrath, Pascal, et al.
Publicado: (2017)

Detection of Candida albicans-Specific CD4+ and CD8+ T Cells in the Blood and Nasal Mucosa of Patients with Chronic Rhinosinusitis
por: Ickrath, Pascal, et al.
Publicado: (2021)

Pilot study on the value of Raman spectroscopy in the entity assignment of salivary gland tumors
por: Meyer, Till Jasper, et al.
Publicado: (2021)

Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer
por: Polat, Bülent, et al.
Publicado: (2017)

The Radiosensitizing Effect of Zinc Oxide Nanoparticles in Sub-Cytotoxic Dosing Is Associated with Oxidative Stress In Vitro
por: Meyer, Till Jasper, et al.
Publicado: (2019)

The Impact of Tissue Preparation on Salivary Gland Tumors Investigated by Fourier-Transform Infrared Microspectroscopy
por: Stefanakis, Mona, et al.
Publicado: (2023)

Long-Term Impact of Zinc Oxide Nanoparticles on Differentiation and Cytokine Secretion of Human Adipose-Derived Stromal Cells
por: Radeloff, Katrin, et al.
Publicado: (2019)

Rare Diseases of Larynx, Trachea and Thyroid
por: Hackenberg, Stephan, et al.
Publicado: (2021)

Toxicity and Functional Impairment in Human Adipose Tissue-Derived Stromal Cells (hASCs) Following Long-Term Exposure to Very Small Iron Oxide Particles (VSOPs)
por: Radeloff, Katrin, et al.
Publicado: (2020)

Somatostatin Receptor–Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas
por: Zhi, Yingjun, et al.
Publicado: (2023)

Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro
por: SCHERZAD, AGMAL, et al.
Publicado: (2016)

Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines
por: Wohlleben, Gisela, et al.
Publicado: (2015)

Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
por: Maletzki, Claudia, et al.
Publicado: (2023)

Effects of Zinc Oxide Nanoparticles in HUVEC: Cyto- and Genotoxicity and Functional Impairment After Long-Term and Repetitive Exposure in vitro
por: Poier, Nikolaus, et al.
Publicado: (2020)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Susceptibility of Human Airway Tissue Models Derived From Different Anatomical Sites to Bordetella pertussis and Its Virulence Factor Adenylate Cyclase Toxin
por: Sivarajan, Rinu, et al.
Publicado: (2021)

Superparamagnetic Iron Oxide Particles (VSOPs) Show Genotoxic Effects but No Functional Impact on Human Adipose Tissue-Derived Stromal Cells (ASCs)
por: Radeloff, Katrin, et al.
Publicado: (2021)

Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
por: dos Santos, Lucas V., et al.
Publicado: (2021)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
por: Ho, Alan L., et al.
Publicado: (2021)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Manukian, Gregor, et al.
Publicado: (2019)

Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Park, Jong Chul, et al.
Publicado: (2022)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
por: Suzuki, Susumu, et al.
Publicado: (2020)

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2017)

PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
por: Evrard, D., et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g5fo7cme3itmtsm13dpi6v9qie